Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.95 HKD | +3.86% | +17.88% | -28.82% |
Apr. 12 | Keymed Biosciences Advances Solid Tumors Drug With First Patient Study | MT |
Mar. 27 | KeyMed Biosciences’ Attributable Loss Widens in 2023 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-28.82% | 1.19B | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- 2162 Stock
- News Keymed Biosciences Inc.
- CSPC Pharma Strikes Licensing Deal for China Rights to Keymed Bio's Allergy Drug